Trials / Completed
CompletedNCT07211425
A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood
The Effect of Multiple Doses of Itraconazole on the Single-dose Pharmacokinetics of BI 3031185 Following Oral Administration in Healthy Trial Participants (an Open-label, Two-period, Fixed- Sequence Design Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect of multiple oral doses of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics of a single dose of BI 3031185 following oral administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 3031185 | BI 3031185 |
| DRUG | Itraconazole | Itraconazole |
Timeline
- Start date
- 2025-10-08
- Primary completion
- 2026-01-21
- Completion
- 2026-01-21
- First posted
- 2025-10-08
- Last updated
- 2026-02-04
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07211425. Inclusion in this directory is not an endorsement.